UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Burden of atopic dermatitis in Asia

Journal of dermatology, 2019-10, Vol.46 (10), p.825-834

2019

Volltextzugriff (PDF)

Intravascular Ultrasound Versus Angiography-Guided Drug-Eluting Stent Implantation: A Health Economic Analysis

Circulation Cardiovascular quality and outcomes, 2021-05, Vol.14 (5), p.e006789-e006789

2021

Volltextzugriff (PDF)

Unité Rhumatologique des Affections de la Main (URAM) scale: Development and validation of a tool to assess Dupuytren's disease–specific disability

Arthritis care & research (2010), 2011-10, Vol.63 (10), p.1448-1455

2011

Volltextzugriff (PDF)

Evaluating the Efficacy of Crisaborole Using the Atopic Dermatitis Severity Index and Percentage of Affected Body Surface Area

Acta dermato-venereologica, 2020-06, Vol.100 (13), p.adv00170-adv00170

2020

Volltextzugriff (PDF)

A SENIOR moment? Bare-metal stents in elderly patients

The Lancet (British edition), 2018-01, Vol.391 (10115), p.4-6

2018

Volltextzugriff (PDF)

Dupuytren's contracture: a retrospective database analysis to assess clinical management and costs in England

BMC musculoskeletal disorders, 2011-04, Vol.12 (1), p.73-73, Article 73

2011

Volltextzugriff (PDF)

Modelling the cost-effectiveness of tofacitinib for the treatment of rheumatoid arthritis in the United States

Current medical research and opinion, 2018-11, Vol.34 (11), p.1991-2000

2018

Volltextzugriff (PDF)

Patient impact and economic burden of mild-to-moderate atopic dermatitis

Current medical research and opinion, 2018-12, Vol.34 (12), p.2177-2185

2018

Volltextzugriff (PDF)

An Economic Evaluation of Tofacitinib Treatment in Rheumatoid Arthritis After Methotrexate or After 1 or 2 TNF Inhibitors from a U.S. Payer Perspective

Journal of managed care & specialty pharmacy, 2018-10, Vol.24 (10), p.1010-1017

2018

Volltextzugriff (PDF)

Comparison of methods for delivering a lifestyle modification program for obese patients: a randomized trial

Annals of internal medicine, 2009-02, Vol.150 (4), p.255

2009

Volltextzugriff (PDF)

Real-World Comparative Effectiveness of Tofacitinib and Tumor Necrosis Factor Inhibitors as Monotherapy and Combination Therapy for Treatment of Rheumatoid Arthritis

Rheumatology and therapy., 2019-12, Vol.6 (4), p.573-586

2019

Volltextzugriff (PDF)

Likelihood-Free Hypothesis Testing

IEEE transactions on information theory, 2024-11, Vol.70 (11), p.7971-8000

2024

Volltextzugriff (PDF)

Adult, adolescent, and caregiver preferences for attributes of topical treatments for mild-to-moderate atopic dermatitis: a discrete-choice experiment

The Journal of dermatological treatment, 2024-12, Vol.35 (1), p.2304020-2304020

2024

Volltextzugriff (PDF)

TCTAP C-095 LIMA Embolization to Treat Iatrogenic Post CABG Complication

Journal of the American College of Cardiology, 2019-04, Vol.73 (15), p.S163-S163

Gerber, Robert

2019

Volltextzugriff (PDF)

Direct and Indirect Effects of Crisaborole Ointment on Quality of Life in Patients with Atopic Dermatitis: A Mediation Analysis

Acta dermato-venereologica, 2019-07, Vol.99 (9), p.756-761

2019

Volltextzugriff (PDF)

Tofacitinib versus Biologic Treatments in Moderate-to-Severe Rheumatoid Arthritis Patients Who Have Had an Inadequate Response to Nonbiologic DMARDs: Systematic Literature Review and Network Meta-Analysis

International journal of rheumatology, 2017-01, Vol.2017 (2017), p.1-15

2017

Volltextzugriff (PDF)

Tofacitinib in the treatment of moderate-to-severe rheumatoid arthritis: a cost-effectiveness analysis compared with adalimumab in Taiwan

Journal of medical economics, 2019-08, Vol.22 (8), p.777-787

2019

Volltextzugriff (PDF)

Prevalence of inadequate glycemic control among patients with type 2 diabetes in the United Kingdom general practice research database: A series of retrospective analyses of data from 1998 through 2002

Clinical therapeutics, 2006-03, Vol.28 (3), p.388-395

2006

Volltextzugriff (PDF)

Patient Satisfaction and Glycemic Control After 1 Year With Inhaled Insulin (Exubera) in Patients With Type 1 or Type 2 Diabetes

Diabetes care, 2004-06, Vol.27 (6), p.1318-1323

2004

Volltextzugriff (PDF)

Initial Experience With Tofacitinib in Clinical Practice: Treatment Patterns and Costs of Tofacitinib Administered as Monotherapy or in Combination With Conventional Synthetic DMARDs in 2 US Health Care Claims Databases

Clinical therapeutics, 2016-06, Vol.38 (6), p.1451-1463

2016

Volltextzugriff (PDF)

The Challenge of Managing Atopic Dermatitis in the United States

American health & drug benefits, 2019-04, Vol.12 (2), p.83-93

2019

Volltextzugriff (PDF)

Topical treatment utilization for patients with atopic dermatitis in the United States, and budget impact analysis of crisaborole ointment, 2

Journal of medical economics, 2018-08, Vol.21 (8), p.770-777

2018

Volltextzugriff (PDF)

An Economic Evaluation of Tofacitinib Treatment in Rheumatoid Arthritis: Modeling the Cost of Treatment Strategies in the United States

Journal of managed care & specialty pharmacy, 2016-09, Vol.22 (9), p.1088-1102

2016

Volltextzugriff (PDF)

Crisaborole Ointment, 2%, for Treatment of Patients with Mild-to-Moderate Atopic Dermatitis: Systematic Literature Review and Network Meta-Analysis

Dermatology and therapy, 2020-08, Vol.10 (4), p.681-694

2020

Volltextzugriff (PDF)

1 – 25 von 1.327

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.125)
Mit Volltextzugriff
(1.097)

Publikationsform

4 weitere anzeigen...

Weniger anzeigen...

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Burden of atopic dermatitis in Asia

Intravascular Ultrasound Versus Angiography-Guided Drug-Eluting Stent Implantation: A Health Economic Analysis

Unité Rhumatologique des Affections de la Main (URAM) scale: Development and validation of a tool to assess Dupuytren's disease–specific disability

Evaluating the Efficacy of Crisaborole Using the Atopic Dermatitis Severity Index and Percentage of Affected Body Surface Area

A SENIOR moment? Bare-metal stents in elderly patients

Dupuytren's contracture: a retrospective database analysis to assess clinical management and costs in England

Modelling the cost-effectiveness of tofacitinib for the treatment of rheumatoid arthritis in the United States

Patient impact and economic burden of mild-to-moderate atopic dermatitis

An Economic Evaluation of Tofacitinib Treatment in Rheumatoid Arthritis After Methotrexate or After 1 or 2 TNF Inhibitors from a U.S. Payer Perspective

Comparison of methods for delivering a lifestyle modification program for obese patients: a randomized trial

Real-World Comparative Effectiveness of Tofacitinib and Tumor Necrosis Factor Inhibitors as Monotherapy and Combination Therapy for Treatment of Rheumatoid Arthritis

Likelihood-Free Hypothesis Testing

Adult, adolescent, and caregiver preferences for attributes of topical treatments for mild-to-moderate atopic dermatitis: a discrete-choice experiment

TCTAP C-095 LIMA Embolization to Treat Iatrogenic Post CABG Complication

Direct and Indirect Effects of Crisaborole Ointment on Quality of Life in Patients with Atopic Dermatitis: A Mediation Analysis

Tofacitinib versus Biologic Treatments in Moderate-to-Severe Rheumatoid Arthritis Patients Who Have Had an Inadequate Response to Nonbiologic DMARDs: Systematic Literature Review and Network Meta-Analysis

Tofacitinib in the treatment of moderate-to-severe rheumatoid arthritis: a cost-effectiveness analysis compared with adalimumab in Taiwan

Comparison of One-Year Outcomes in Patients >75 Versus ≤75 Years With Coronary Artery Disease Treated With COMBO Stents (From The MASCOT Registry)

Prevalence of inadequate glycemic control among patients with type 2 diabetes in the United Kingdom general practice research database: A series of retrospective analyses of data from 1998 through 2002

Patient Satisfaction and Glycemic Control After 1 Year With Inhaled Insulin (Exubera) in Patients With Type 1 or Type 2 Diabetes

Initial Experience With Tofacitinib in Clinical Practice: Treatment Patterns and Costs of Tofacitinib Administered as Monotherapy or in Combination With Conventional Synthetic DMARDs in 2 US Health Care Claims Databases

The Challenge of Managing Atopic Dermatitis in the United States

Topical treatment utilization for patients with atopic dermatitis in the United States, and budget impact analysis of crisaborole ointment, 2

An Economic Evaluation of Tofacitinib Treatment in Rheumatoid Arthritis: Modeling the Cost of Treatment Strategies in the United States

Crisaborole Ointment, 2%, for Treatment of Patients with Mild-to-Moderate Atopic Dermatitis: Systematic Literature Review and Network Meta-Analysis

Suchergebnisse filtern